Pharmacokinetics of milrinone with congestive heart failure

Pharmacokinetics of milrinone with congestive heart failure - Pharmacokinetics of milrinone with congestive heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048102

Enrollment

100

Registered

2022-06-20

Start date

2021-09-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients using milrinone after cardiopulmonary bypass during cardiovascular surgery

Exclusion criteria

Exclusion criteria: Patients more than 20% circadian variation in renal function over 12 hours

Design outcomes

Primary

Measure	Time frame
Volume of distribution, clearance and lowest blood concentration	—

Countries

Japan

Contacts

Public ContactTakahiro Tamura

Nagoya University Graduate School of Medicine Anesthesiology

takahiro@med.nagoya-u.ac.jp0527412111

Outcome results